Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Patients' perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study.

Aibana O, Dauria E, Kiriazova T, Makarenko O, Bachmaha M, Rybak N, Flanigan TP, Petrenko V, Becker AE, Murray MB.

BMJ Open. 2020 Feb 2;10(1):e032027. doi: 10.1136/bmjopen-2019-032027.

2.

Two clinical prediction tools to improve tuberculosis contact investigation.

Li R, Nordio F, Huang CC, Contreras C, Calderon R, Yataco R, Galea JT, Zhang Z, Becerra MC, Lecca L, Murray MB.

Clin Infect Dis. 2020 Jan 6. pii: ciz1221. doi: 10.1093/cid/ciz1221. [Epub ahead of print]

PMID:
31905406
3.

A TCR β-Chain Motif Biases toward Recognition of Human CD1 Proteins.

Reinink P, Shahine A, Gras S, Cheng TY, Farquhar R, Lopez K, Suliman SA, Reijneveld JF, Le Nours J, Tan LL, León SR, Jimenez J, Calderon R, Lecca L, Murray MB, Rossjohn J, Moody DB, Van Rhijn I.

J Immunol. 2019 Dec 15;203(12):3395-3406. doi: 10.4049/jimmunol.1900872. Epub 2019 Nov 6.

PMID:
31694911
4.

Correction to: Detection of Mycobacterium tuberculosis in pediatric stool samples using TruTip technology.

Mesman AW, Soto M, Coit J, Calderon R, Aliaga J, Pollock NR, Mendoza M, Mestanza FM, Mendoza CJ, Murray MB, Lecca L, Holmberg R, Franke MF.

BMC Infect Dis. 2019 Oct 16;19(1):856. doi: 10.1186/s12879-019-4483-4.

5.

Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis.

Aibana O, Huang CC, Aboud S, Arnedo-Pena A, Becerra MC, Bellido-Blasco JB, Bhosale R, Calderon R, Chiang S, Contreras C, Davaasambuu G, Fawzi WW, Franke MF, Galea JT, Garcia-Ferrer D, Gil-Fortuño M, Gomila-Sard B, Gupta A, Gupte N, Hussain R, Iborra-Millet J, Iqbal NT, Juan-Cerdán JV, Kinikar A, Lecca L, Mave V, Meseguer-Ferrer N, Montepiedra G, Mugusi FM, Owolabi OA, Parsonnet J, Roach-Poblete F, Romeu-García MA, Spector SA, Sudfeld CR, Tenforde MW, Togun TO, Yataco R, Zhang Z, Murray MB.

PLoS Med. 2019 Sep 11;16(9):e1002907. doi: 10.1371/journal.pmed.1002907. eCollection 2019 Sep.

6.

Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians.

Luo Y, Suliman S, Asgari S, Amariuta T, Baglaenko Y, Martínez-Bonet M, Ishigaki K, Gutierrez-Arcelus M, Calderon R, Lecca L, León SR, Jimenez J, Yataco R, Contreras C, Galea JT, Becerra M, Nejentsev S, Nigrovic PA, Moody DB, Murray MB, Raychaudhuri S.

Nat Commun. 2019 Aug 21;10(1):3765. doi: 10.1038/s41467-019-11664-1.

7.

Detection of Mycobacterium tuberculosis in pediatric stool samples using TruTip technology.

Mesman AW, Soto M, Coit J, Calderon R, Aliaga J, Pollock NR, Mendoza M, Mestanza FM, Mendoza CJ, Murray MB, Lecca L, Holmberg R, Franke MF.

BMC Infect Dis. 2019 Jun 27;19(1):563. doi: 10.1186/s12879-019-4188-8. Erratum in: BMC Infect Dis. 2019 Oct 16;19(1):856.

8.

Neuroterrorism Preparedness for the Neurohospitalist.

Ralston MSA, Murray MBP, Vela-Duarte D, Orjuela KD, Pastula DM.

Neurohospitalist. 2019 Jul;9(3):151-159. doi: 10.1177/1941874418806668. Epub 2018 Oct 21. Review.

PMID:
31244972
9.

Spatial-temporal clustering analysis of yaws on Lihir Island, Papua New Guinea to enhance planning and implementation of eradication programs.

Mooring EQ, Mitjà O, Murray MB.

PLoS Negl Trop Dis. 2018 Oct 29;12(10):e0006840. doi: 10.1371/journal.pntd.0006840. eCollection 2018 Oct.

10.

Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysis.

McIntosh AI, Jenkins HE, White LF, Barnard M, Thomson DR, Dolby T, Simpson J, Streicher EM, Kleinman MB, Ragan EJ, van Helden PD, Murray MB, Warren RM, Jacobson KR.

PLoS Med. 2018 Aug 21;15(8):e1002638. doi: 10.1371/journal.pmed.1002638. eCollection 2018 Aug.

11.

Automated TruTip nucleic acid extraction and purification from raw sputum.

Thakore N, Norville R, Franke M, Calderon R, Lecca L, Villanueva M, Murray MB, Cooney CG, Chandler DP, Holmberg RC.

PLoS One. 2018 Jul 5;13(7):e0199869. doi: 10.1371/journal.pone.0199869. eCollection 2018.

12.

Cohort Profile: Ifanadiana Health Outcomes and Prosperity longitudinal Evaluation (IHOPE).

Miller AC, Garchitorena A, Rabeza V, Randriamanambintsoa M, Rahaniraka Razanadrakato HT, Cordier L, Ouenzar MA, Murray MB, Thomson DR, Bonds MH.

Int J Epidemiol. 2018 Oct 1;47(5):1394-1395e. doi: 10.1093/ije/dyy099. No abstract available.

PMID:
29939260
13.

Early changes in intervention coverage and mortality rates following the implementation of an integrated health system intervention in Madagascar.

Garchitorena A, Miller AC, Cordier LF, Rabeza VR, Randriamanambintsoa M, Razanadrakato HR, Hall L, Gikic D, Haruna J, McCarty M, Randrianambinina A, Thomson DR, Atwood S, Rich ML, Murray MB, Ratsirarson J, Ouenzar MA, Bonds MH.

BMJ Glob Health. 2018 Jun 4;3(3):e000762. doi: 10.1136/bmjgh-2018-000762. eCollection 2018.

14.

Impact of a health system strengthening intervention on maternal and child health outputs and outcomes in rural Rwanda 2005-2010.

Thomson DR, Amoroso C, Atwood S, Bonds MH, Rwabukwisi FC, Drobac P, Finnegan KE, Farmer DB, Farmer PE, Habinshuti A, Hirschhorn LR, Manzi A, Niyigena P, Rich ML, Stulac S, Murray MB, Binagwaho A.

BMJ Glob Health. 2018 Apr 9;3(2):e000674. doi: 10.1136/bmjgh-2017-000674. eCollection 2018.

15.

T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids.

Wun KS, Reijneveld JF, Cheng TY, Ladell K, Uldrich AP, Le Nours J, Miners KL, McLaren JE, Grant EJ, Haigh OL, Watkins TS, Suliman S, Iwany S, Jimenez J, Calderon R, Tamara KL, Leon SR, Murray MB, Mayfield JA, Altman JD, Purcell AW, Miles JJ, Godfrey DI, Gras S, Price DA, Van Rhijn I, Moody DB, Rossjohn J.

Nat Immunol. 2018 Apr;19(4):397-406. doi: 10.1038/s41590-018-0065-7. Epub 2018 Mar 12.

16.

Vitamin E Status Is Inversely Associated with Risk of Incident Tuberculosis Disease among Household Contacts.

Aibana O, Franke MF, Huang CC, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Contreras C, Yataco R, Lecca L, Murray MB.

J Nutr. 2018 Jan 1;148(1):56-62. doi: 10.1093/jn/nxx006.

17.

Genotyping Multidrug-Resistant Mycobacterium tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray Test.

Linger Y, Knickerbocker C, Sipes D, Golova J, Franke M, Calderon R, Lecca L, Thakore N, Holmberg R, Qu P, Kukhtin A, Murray MB, Cooney CG, Chandler DP.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01652-17. doi: 10.1128/JCM.01652-17. Print 2018 Mar.

18.

Corrigendum: High-throughput discovery of novel developmental phenotypes.

Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu H, Baker CN, Bower L, Brown JM, Caddle LB, Chiani F, Clary D, Cleak J, Daly MJ, Denegre JM, Doe B, Dolan ME, Edie Helmut Fuchs SM, Gailus-Durner V, Galli A, Gambadoro A, Gallegos J, Guo S, Horner NR, Hsu CW, Johnson SJ, Kalaga S, Keith LC, Lanoue L, Lawson TN, Lek M, Mark M, Marschall S, Mason J, McElwee ML, Nutter SNLMJ, Peterson KA, Ramirez-Solis R, Rowland DJ, Ryder E, Samocha KE, Seavitt JR, Selloum M, Szoke-Kovacs Z, Tamura M, Trainor AG, Tudose I, Wakana S, Warren J, Wendling O, West DB, Wong L, Yoshiki A; International Mouse Phenotyping Consortium, Wurst W, MacArthur DG, Tocchini-Valentini GP, Gao X, Flicek P, Bradley A, Skarnes WC, Justice MJ, Parkinson HE, Moore M, Wells S, Braun RE, Svenson KL, de Angelis MH, Herault Y, Mohun T, Mallon AM, Henkelman RM, Brown SDM, Adams DJ, Lloyd KCK, McKerlie C, Beaudet AL, Murray MBSA.

Nature. 2017 Nov 16;551(7680):398. doi: 10.1038/nature24643. Epub 2017 Nov 8.

19.

Patient predictors of poor drug sensitive tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.

Aibana O, Slavuckij A, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Murray MB.

F1000Res. 2017 Oct 23;6:1873. doi: 10.12688/f1000research.12687.3. eCollection 2017.

20.

Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.

Nathavitharana RR, Shi CX, Chindelevitch L, Calderon R, Zhang Z, Galea JT, Contreras C, Yataco R, Lecca L, Becerra MC, Murray MB, Cohen T.

Emerg Infect Dis. 2017 Nov;23(11):1887-1890. doi: 10.3201/eid2311.170077.

21.

Development and Validation of a Food Frequency Questionnaire to Estimate Intake among Children and Adolescents in Urban Peru.

Rodriguez CA, Smith ER, Villamor E, Zavaleta N, Respicio-Torres G, Contreras C, Perea S, Jimenez J, Tintaya K, Lecca L, Murray MB, Franke MF.

Nutrients. 2017 Oct 14;9(10). pii: E1121. doi: 10.3390/nu9101121.

22.

Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.

Calderón RI, Velásquez GE, Becerra MC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Kritski AL, Murray MB, Mitnick CD.

Int J Tuberc Lung Dis. 2017 Aug 1;21(8):894-901. doi: 10.5588/ijtld.16.0850.

23.

Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.

Aibana O, Franke MF, Huang CC, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Ronnenberg AG, Contreras C, Yataco R, Lecca L, Murray MB.

Clin Infect Dis. 2017 Sep 15;65(6):900-909. doi: 10.1093/cid/cix476.

24.

Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e00069-17. doi: 10.1128/AAC.00069-17. Print 2017 Mar. No abstract available.

25.

Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.

Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Murray MB.

BMC Infect Dis. 2017 Feb 7;17(1):129. doi: 10.1186/s12879-017-2230-2.

26.

Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.

Richardson ET, Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Marsh RH, Koedoyoma S, Daboh F, Barron KP, Grady M, Tucker E, Dierberg KL, Rutherford GW, Barry M, Jones JH, Murray MB, Farmer PE.

PLoS Negl Trop Dis. 2016 Nov 15;10(11):e0005087. doi: 10.1371/journal.pntd.0005087. eCollection 2016 Nov.

27.

Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts.

Aibana O, Acharya X, Huang CC, Becerra MC, Galea JT, Chiang SS, Contreras C, Calderon R, Yataco R, Velásquez GE, Tintaya K, Jimenez J, Lecca L, Murray MB.

PLoS One. 2016 Nov 11;11(11):e0166333. doi: 10.1371/journal.pone.0166333. eCollection 2016.

28.

Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6766-6773. doi: 10.1128/AAC.00632-16. Print 2016 Nov. Erratum in: Antimicrob Agents Chemother. 2017 Feb 23;61(3):.

29.

Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model.

Diakite I, Mooring EQ, Velásquez GE, Murray MB.

PLoS Negl Trop Dis. 2016 Aug 10;10(8):e0004866. doi: 10.1371/journal.pntd.0004866. eCollection 2016 Aug.

30.

Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis.

Lahiri N, Shah RR, Layre E, Young D, Ford C, Murray MB, Fortune SM, Moody DB.

J Biol Chem. 2016 Jul 1;291(27):14248-56. doi: 10.1074/jbc.M116.716704. Epub 2016 May 10.

31.

Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India.

Atre SR, Murray MB.

J Public Health Policy. 2016 Aug;37(3):277-299. doi: 10.1057/jphp.2016.14. Epub 2016 May 6. Review.

PMID:
27153155
32.

Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study.

Velásquez GE, Cegielski JP, Murray MB, Yagui MJ, Asencios LL, Bayona JN, Bonilla CA, Jave HO, Yale G, Suárez CZ, Sanchez E, Rojas C, Atwood SS, Contreras CC, Santa Cruz J, Shin SS.

BMC Infect Dis. 2016 Feb 1;16:45. doi: 10.1186/s12879-016-1375-8.

33.

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants.

Odone A, Calderon R, Becerra MC, Zhang Z, Contreras CC, Yataco R, Galea J, Lecca L, Bonds MH, Mitnick CD, Murray MB.

PLoS One. 2016 Jan 14;11(1):e0146642. doi: 10.1371/journal.pone.0146642. eCollection 2016.

34.

[The epidemiological advantage of preferential targeting of tuberculosis control at the poor].

Andrews JR, Basu S, Dowdy DW, Murray MB.

Rev Panam Salud Publica. 2015 Sep;38(3):186-94. Spanish.

PMID:
26757996
35.
36.

Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data.

Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Manjourides J, Grenfell BT, Cohen T.

J Infect Dis. 2016 Jan 15;213(2):287-94. doi: 10.1093/infdis/jiv387. Epub 2015 Jul 14.

37.

Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review.

Velásquez GE, Aibana O, Ling EJ, Diakite I, Mooring EQ, Murray MB.

Clin Infect Dis. 2015 Oct 1;61(7):1135-40. doi: 10.1093/cid/civ531. Epub 2015 Jun 30. Review.

38.

The epidemiological advantage of preferential targeting of tuberculosis control at the poor.

Andrews JR, Basu S, Dowdy DW, Murray MB.

Int J Tuberc Lung Dis. 2015 Apr;19(4):375-80. doi: 10.5588/ijtld.14.0423. Review. Erratum in: Int J Tuberc Lung Dis. 2015 Aug;19(8):1000.

39.

Modelling challenges in context: lessons from malaria, HIV, and tuberculosis.

Childs LM, Abuelezam NN, Dye C, Gupta S, Murray MB, Williams BG, Buckee CO.

Epidemics. 2015 Mar;10:102-7. doi: 10.1016/j.epidem.2015.02.002. Epub 2015 Feb 16.

40.

Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis.

Ivers LC, Hilaire IJ, Teng JE, Almazor CP, Jerome JG, Ternier R, Boncy J, Buteau J, Murray MB, Harris JB, Franke MF.

Lancet Glob Health. 2015 Mar;3(3):e162-8. doi: 10.1016/S2214-109X(14)70368-7.

41.

Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy.

Krumme AA, Kaigamba F, Binagwaho A, Murray MB, Rich ML, Franke MF.

J Epidemiol Community Health. 2015 Mar;69(3):284-9. doi: 10.1136/jech-2014-204494. Epub 2014 Nov 10.

PMID:
25385745
42.

Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting.

Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Grenfell BT, Cohen T.

Am J Epidemiol. 2014 Oct 15;180(8):853-61. doi: 10.1093/aje/kwu192. Epub 2014 Sep 4.

43.

A novel approach - the propensity to propagate (PTP) method for controlling for host factors in studying the transmission of Mycobacterium tuberculosis.

Nebenzahl-Guimaraes H, Borgdorff MW, Murray MB, van Soolingen D.

PLoS One. 2014 May 21;9(5):e97816. doi: 10.1371/journal.pone.0097816. eCollection 2014.

44.

Poverty, disease, and the ecology of complex systems.

Ngonghala CN, Pluciński MM, Murray MB, Farmer PE, Barrett CB, Keenan DC, Bonds MH.

PLoS Biol. 2014 Apr 1;12(4):e1001827. doi: 10.1371/journal.pbio.1001827. eCollection 2014 Apr.

45.

Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis.

Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Grenfell BT, Cohen T.

Am J Respir Crit Care Med. 2014 Apr 1;189(7):853-9. doi: 10.1164/rccm.201310-1896OC.

46.

Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort study.

Kendall EA, Theron D, Franke MF, van Helden P, Victor TC, Murray MB, Warren RM, Jacobson KR.

PLoS One. 2013 Dec 13;8(12):e83480. doi: 10.1371/journal.pone.0083480. eCollection 2013.

47.

Peristaltic pulse dynamic compression of the lower extremity enhances flexibility.

Sands WA, Murray MB, Murray SR, McNeal JR, Mizuguchi S, Sato K, Stone MH.

J Strength Cond Res. 2014 Apr;28(4):1058-64. doi: 10.1519/JSC.0000000000000244.

PMID:
24077383
48.

Modifiable factors associated with tuberculosis disease in children: a case-control study.

Franke MF, del Castillo H, Pereda Y, Lecca L, Cárdenas L, Fuertes J, Murray MB, Bayona J, Becerra MC.

Pediatr Infect Dis J. 2014 Jan;33(1):109-11. doi: 10.1097/INF.0000000000000000.

PMID:
24064556
49.

Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.

Nebenzahl-Guimaraes H, Jacobson KR, Farhat MR, Murray MB.

J Antimicrob Chemother. 2014 Feb;69(2):331-42. doi: 10.1093/jac/dkt358. Epub 2013 Sep 20. Review.

50.

Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.

Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM.

Nat Genet. 2013 Jul;45(7):784-90. doi: 10.1038/ng.2656. Epub 2013 Jun 9.

Supplemental Content

Loading ...
Support Center